Status:
RECRUITING
Voice Analysis for Monitoring Patients With Heart Failure
Lead Sponsor:
Noah Labs
Collaborating Sponsors:
Charite University, Berlin, Germany
Mayo Clinic
Conditions:
Heart Failure
Eligibility:
All Genders
18+ years
Brief Summary
This observational study involves ADHF patients at two sites in the United States and Germany. After informed consent and screening assessments, participants will perform daily voice recordings during...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Clinically diagnosed with Acutely Decompensated Heart Failure.
- At least 18 years of age.
- Exclusion criteria:
- Disabling mental diseases (e.g., Alzheimer's disease)
- Clinically diagnosed chronic obstructive pulmonary disease (COPD)
- Treatment in ICU or IMU
- Dialysis treatment
- Previous operations on organs involved in generation of voice (vocal tract, vocal folds, etc.)
- Neurodegenerative diseases
- Pregnancy
- Inability to provide consent
Exclusion
Key Trial Info
Start Date :
January 24 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2024
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT06566911
Start Date
January 24 2024
End Date
September 1 2024
Last Update
August 22 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic
Rochester, Minnesota, United States, 55902
2
Deutsches Herzzentrum der Charité
Berlin, Germany, 13353